Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 75.32% is 38% above its 5-year average of 54.64%, near the high end of its 5-year range (13.16%–83.28%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.54% below its 12-month average of 79.74%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 75.32%.
DEBT TO ASSETS RATIO
75.32%
DEBT TO ASSETS RATIO AVG TTM
79.74%
DEBT TO ASSETS RATIO AVG 3Y
68.92%
DEBT TO ASSETS RATIO AVG 5Y
54.64%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-5.54%
CURRENT VS 3Y AVG
+9.27%
CURRENT VS 5Y AVG
+37.84%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 809 covered companies
CURRENT VS SECTOR MEDIAN
+83584.76%
vs the sector median at left
Biodesix, Inc.
Market Cap
$232.00M
Debt to Assets Ratio
75.32%
TTM Avg
79.74%
3Y Avg
68.92%
5Y Avg
54.64%
Market Cap
$236.39M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$236.69M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$224.38M
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biodesix, Inc. (BDSX) | $232.00M | 75.32% | 79.74% | 68.92% | 54.64% |
| MacroGenics, Inc. (MGNX)vs › | $232.32M | 0.10% | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $229.57M | 0.01% | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $236.39M | 0.15% | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $236.41M | 0.00% | N/A | N/A | N/A |
| SIGA Technologies, Inc. (SIGA)vs › | $236.69M | 0.00% | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $237.39M | 0.04% | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $237.69M | 0.33% | N/A | N/A | N/A |
| Profound Medical Corp. (PROF)vs › | $224.38M | 0.12% | N/A | N/A | N/A |
| Q32 Bio Inc. (QTTB)vs › | $240.61M | 0.05% | N/A | N/A | N/A |
Debt/Assets
75.3%
Debt/Equity
7.85
Current Ratio
2.85
Interest Coverage
-3.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 75.32% |
| 2026-03-31 | 75.67% |
| 2025-12-31 | 83.28% |
| 2025-09-30 | 82.20% |
| 2025-06-30 | 82.22% |
| 2025-03-31 | 72.22% |
| 2024-12-31 | 63.73% |
| 2024-09-30 | 60.30% |
| 2024-06-30 | 53.20% |
| 2024-03-31 | 70.15% |
| 2023-12-31 | 61.24% |
| 2023-09-30 | 58.48% |
| 2023-06-30 | 58.00% |
| 2023-03-31 | 48.19% |
| 2022-12-31 | 34.28% |
| 2022-09-30 | 37.19% |
| 2022-06-30 | 32.68% |
| 2022-03-31 | 20.10% |
| 2021-12-31 | 13.16% |
| 2021-09-30 | 33.33% |
| 2021-06-30 | 32.48% |
| 2021-03-31 | 28.61% |
| 2020-12-31 | 22.93% |
| 2020-09-30 | 116.31% |
| 2020-06-30 | 60.07% |
| 2019-12-31 | 79.88% |
